Does normoxemic cardiopulmonary bypass prevent myocardial reoxygenation injury in cyanotic children?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 16, Issue 3, 2002, Pages 330-333

  Bulutcu, Füsun S ^a   Bayindir, Osman ^a   Polat, Bülent ^a   Yalcin, Yalim ^a   Özbek, Uǧur ^a   Cakali, Emine ^a  

^a KADIR HAS UNIVERSITY   (Turkey)

Author keywords

Antioxidant reserve capacity; Cardiopulmonary bypass (CPB); Cyanotic congenital heart; Reoxygenation injury

Indexed keywords

ANTIOXIDANT; FENTANYL; INTERLEUKIN 6; MALONALDEHYDE; MIDAZOLAM; PROTAMINE; TERT BUTYL HYDROPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; VECURONIUM; OXYGEN;

ANESTHESIA INDUCTION; AORTA CLAMPING; AORTA COARCTATION; ARTERIAL OXYGEN TENSION; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYANOSIS; FALLOT TETRALOGY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART MUSCLE BIOPSY; HEART MUSCLE INJURY; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HUMAN TISSUE; INFANT; LUNG ATRESIA; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VALVE STENOSIS; RANDOMIZED CONTROLLED TRIAL; REOXYGENATION; TRICUSPID VALVE ATRESIA; VEIN CATHETERIZATION; CONGENITAL HEART MALFORMATION; HEART MUSCLE; LIPID PEROXIDATION; METABOLISM; METHODOLOGY; OXYGENATOR;

ANTIOXIDANTS; CARDIOPULMONARY BYPASS; CHILD, PRESCHOOL; CYANOSIS; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INTERLEUKIN-6; LIPID PEROXIDATION; MALONDIALDEHYDE; MYOCARDIUM; OXYGEN; OXYGENATORS, MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036017630     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2002.124142     Document Type: Article

References (19)

1. Intracardiac surgery in infants under age 3 months: Incremental risk factors for hospital mortality
2. Correlation between antioxidant changes during hypoxia and recovery on reoxygenation
3. Studies of hypoxemic/reoxygenation injury: Without aortic clamping: II. Evidence for reoxygenation damage
4. Studies of hypoxemic/reoxygenation injury: With aortic clamping: XIII. Interaction between oxygen tension and cardioplegic composition in limiting nitric oxide production and oxidant damage
5. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass
6. Elevation of cytokine during open heart surgery with cardiopulmonary bypass: Participation of interleukin 8 and 6 in reperfusion injury
7. Altered antioxidant status in the ischemic/reperfused rabbit myocardium: Effects of allopurinol
8. Deleterious effects of cardiopulmonary bypass: A prospective study of bubble versus membrane oxygenation
9. Studies of hypoxemic/reoxygenation injury: I. Linkage between cardiac function and oxidant damage
10. Role of Larginine-nitric oxide pathway in myocardial reoxygenation injury
11. A oxidative injury in reoxygenated and reperfused hearts
12. Ultrastructural damage associated with reoxygenation of the anoxic myocardium
13. Chronic hypoxemia depresses global ventricular function and predisposes to the depletion of high-energy phosphates during cardioplegic arrest: Implications for surgical repair of cyanotic congenital heart defects
14. Role of oxygen in the cellular damage induced by reoxygenation of hypoxic heart
15. Prevention of the oxygen paradox in hypoxic-reoxygenated hearts
16. Inadequate myocardial protection with cold cardioplegic arrest during repair of tetralogy of Fallot
17. Detrimental effects of cardiopulmonary bypass in cyanotic infants: Preventing the reoxygenation injury
18. Circulating cytokines in patients undergoing normothermic cardiopulomonary bypass
19. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations